ID   HeLa-2T
AC   CVCL_UM63
DR   Wikidata; Q94100490
RX   PubMed=3756862;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI:72568; MTIC (5-(3-methyl-1-triazeno)imidazole-4-carboxamide).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
RX   PubMed=3756862;
RA   Maynard K., Parsons P.G.;
RT   "Cross-sensitivity of methylating agents, hydroxyurea, and
RT   methotrexate in human tumor cells of the Mer- phenotype.";
RL   Cancer Res. 46:5009-5013(1986).
//